Smith & Nephew (SNNUF) EBITDA Margin Growth (1y) (2010 - 2022)
Smith & Nephew (SNNUF) EBITDA Margin Growth (1y) (2010 - 2022) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | -430.00 |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 128.00 |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -361.00 |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 141.00 |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 102.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 58.00 |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 851.00 |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -313.00 |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 535.00 |
| 10 | Smith & Nephew | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 11.00 |
| Dec 31, 2021 | 944.00 |
| Dec 31, 2020 | -1,711.00 |
| Dec 31, 2019 | 162.00 |
| Dec 31, 2018 | -248.00 |
| Dec 31, 2017 | 239.00 |
| Dec 31, 2016 | -399.00 |
| Dec 31, 2015 | 297.00 |
| Dec 31, 2014 | -104.00 |
| Sep 30, 2014 | -359.00 |
| Mar 31, 2014 | -1,695.00 |
| Dec 31, 2013 | -238.00 |
| Sep 28, 2013 | -212.00 |
| Jun 29, 2013 | 3,782.00 |
| Mar 31, 2013 | -502.00 |
| Dec 31, 2012 | 1,978.00 |
| Mar 31, 2012 | -2.01 Bn |
| Dec 31, 2011 | -1,031.00 |
| Mar 31, 2011 | 2.01 Bn |
| Dec 31, 2010 | -1.77 Bn |